Consun Pharmaceutical Group Ltd - ESG Rating & Company Profile powered by AI
Other companies in the rating industry group for Consun Pharmaceutical Group Ltd are shown. This page includes a Q&A table on Consun Pharmaceutical Group Ltd. Complete ESG analysis of Consun Pharmaceutical Group Ltd can be accessed by logging in.
Consun Pharmaceutical Group Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.5; made up of an environmental score of 8.0, social score of 8.0 and governance score of 6.4.
7.5
High ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
149 | Torrent Pharmaceuticals Ltd | 7.6 | High |
149 | Virbac SA | 7.6 | High |
160 | Consun Pharmaceutical Group Ltd | 7.5 | High |
160 | C4X Discovery Holdings PLC | 7.5 | High |
160 | Ascentage Pharma Group International | 7.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Consun Pharmaceutical Group Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Consun Pharmaceutical Group Ltd disclose current and historical energy intensity?
Does Consun Pharmaceutical Group Ltd report the average age of the workforce?
Does Consun Pharmaceutical Group Ltd reference operational or capital allocation in relation to climate change?
Does Consun Pharmaceutical Group Ltd disclose its ethnicity pay gap?
Does Consun Pharmaceutical Group Ltd disclose cybersecurity risks?
Does Consun Pharmaceutical Group Ltd offer flexible work?
Does Consun Pharmaceutical Group Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Consun Pharmaceutical Group Ltd disclose the number of employees in R&D functions?
Does Consun Pharmaceutical Group Ltd conduct supply chain audits?
Does Consun Pharmaceutical Group Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Consun Pharmaceutical Group Ltd conduct 360 degree staff reviews?
Does Consun Pharmaceutical Group Ltd disclose the individual responsible for D&I?
Does Consun Pharmaceutical Group Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Consun Pharmaceutical Group Ltd disclose current and / or historical scope 2 emissions?
Does Consun Pharmaceutical Group Ltd disclose water use targets?
Does Consun Pharmaceutical Group Ltd have careers partnerships with academic institutions?
Did Consun Pharmaceutical Group Ltd have a product recall in the last two years?
Does Consun Pharmaceutical Group Ltd disclose incidents of discrimination?
Does Consun Pharmaceutical Group Ltd allow for Work Councils/Collective Agreements to be formed?
Has Consun Pharmaceutical Group Ltd issued a profit warning in the past 24 months?
Does Consun Pharmaceutical Group Ltd disclose parental leave metrics?
Does Consun Pharmaceutical Group Ltd disclose climate scenario or pathway analysis?
Does Consun Pharmaceutical Group Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Consun Pharmaceutical Group Ltd disclose the pay ratio of women to men?
Does Consun Pharmaceutical Group Ltd support suppliers with sustainability related research and development?
Does Consun Pharmaceutical Group Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Consun Pharmaceutical Group Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Consun Pharmaceutical Group Ltd involved in embryonic stem cell research?
Does Consun Pharmaceutical Group Ltd disclose GHG and Air Emissions intensity?
Does Consun Pharmaceutical Group Ltd disclose its waste policy?
Does Consun Pharmaceutical Group Ltd report according to TCFD requirements?
Does Consun Pharmaceutical Group Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Consun Pharmaceutical Group Ltd disclose energy use targets?
Does Consun Pharmaceutical Group Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Consun Pharmaceutical Group Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Consun Pharmaceutical Group Ltd
These potential risks are based on the size, segment and geographies of the company.
Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates in two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also provides Yuanli Kang, an iron-dextrin oral solution; Yibao Yua, an erythromycin estolate suspension; Yuantong Ning, a cetirizine hydrochloride oral solution; and Zhixueling capsules to treat hysteromyoma bleeding, prolonged lochiorrhea, intermenstrual bleeding, bleeding after use of a contraceptive ring, hemorrhoidal bleeding, and epistaxis. In addition, it offers Gyn Antidysmenorrheic tablets for the treatment of irregular menstruation, irregular period during perimenopause, and abdominal pain during menstruation due to hepatic depression and blood deficiency; and Antibacterial Fujie lotion for staphylococcus aureus, Candida albicans, and escherichia coli in the feminine vaginal. Further, the company provides bone-setting liquid; Yunxiang analgesic tincture for treatment of rheumatism, common cold, headache, stomachache, cardiodynia, and pain in gastral cavity and chilblain; Sanqi Chuangchun capsules for activating blood circulation and dispersing blood stasis; Shiduqing capsules and tablets, and Paeonol ointment for skin disease. Additionally, it offers hepatobiliary, gastroenterology, and other medicines. The company was founded in 1997 and is headquartered in Guangzhou, the People's Republic of China.